Given the potential role of NFKBIA in glioblastoma development and progression15, 16, 17, we aimed to investigate, in LGGs, the impact of NFKBIA dosage and expression on patient survival, overall malignancy and the downstream activation of NFκB. The gene discussed is NFKB1; the disease is glioblastoma.